These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2622593)

  • 21. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO.
    Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS
    Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-tracer SPECT in patients with AIDS encephalopathy: a comparison of 123I-IMP with 99Tcm-HMPAO.
    Pohl P; Riccabona G; Hilty E; Deisenhammer F; Rösslér H; Zangerle R; Gerstenbrand F
    Nucl Med Commun; 1992 Aug; 13(8):586-92. PubMed ID: 1513520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of metabolic alterations on the accumulation of technetium-99m-labeled d,l-HMPAO in slices of rat cerebral cortex.
    Ahn CS; Tow DE; Yu CC; Greene RW
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):324-31. PubMed ID: 8113327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-tracer autoradiography using 125I-iomazenil and 99Tcm-HMPAO in experimental brain ischaemia.
    Matsuda H; Tsuji S; Kuji I; Shiba K; Hisada K; Mori H
    Nucl Med Commun; 1995 Jul; 16(7):581-90. PubMed ID: 7478397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 99Tcm-HMPAO and 99Tcm-DTPA radioaerosol clearance measurements in idiopathic pulmonary fibrosis.
    Yeh SH; Liu RS; Wu LC; Peng NJ; Lu JY
    Nucl Med Commun; 1995 Mar; 16(3):140-4. PubMed ID: 7770236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The radiation dosimetry of 99Tcm-exametazime.
    Soundy RG; Tyrrell DA; Pickett RD; Stabin M
    Nucl Med Commun; 1990 Nov; 11(11):791-9. PubMed ID: 2277692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gallbladder visualization in 99Tcm-HMPAO autologous white cell scintigraphy.
    Neilly JB; Gray HW
    Nucl Med Commun; 1996 Mar; 17(3):243-5. PubMed ID: 8692493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO.
    Jacquier-Sarlin MR; Polla BS; Slosman DO
    J Nucl Med; 1996 Aug; 37(8):1413-6. PubMed ID: 8708786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation to eliminate vascular activity on 99Tcm-HMPAO brain SPECT for regional cerebral blood flow (rCBF) determination.
    Hayashida K; Nishimura T; Imakita S; Uehara T
    Nucl Med Commun; 1991 Jun; 12(6):545-50. PubMed ID: 1866107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The assessment of 99mTc-HMPAO tumor scintigraphy using VX-2 tumors in rabbits].
    Suga K; Uchisako H; Honma Y; Kuramitsu T; Itoh K; Nakagi K; Tanaka N; Ariyoshi I; Nakanishi T; Utsumi H
    Kaku Igaku; 1991 Sep; 28(9):1049-56. PubMed ID: 1770657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione.
    Neirinckx RD; Burke JF; Harrison RC; Forster AM; Andersen AR; Lassen NA
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S4-12. PubMed ID: 3192641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
    Léveillé J; Demonceau G; Walovitch RC
    J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection.
    Goins B; Klipper R; Rudolph AS; Cliff RO; Blumhardt R; Phillips WT
    J Nucl Med; 1993 Dec; 34(12):2160-8. PubMed ID: 8254404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioleucoscintigraphy in osteoarthritis. Is there an inflammatory component?
    al-Janabi MA; Solanki K; Critchley M; Smith ML; Britton KE; Huskisson EC
    Nucl Med Commun; 1992 Oct; 13(10):706-12. PubMed ID: 1491834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.
    Rubin RT; Villanueva-Meyer J; Ananth J; Trajmar PG; Mena I
    Arch Gen Psychiatry; 1992 Sep; 49(9):695-702. PubMed ID: 1514874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
    Andersen AR
    Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigations of brain tumours with 99Tcm-HMPAO SPECT.
    Langen KJ; Roosen N; Herzog H; Kuwert T; Kiwit JC; Bock WJ; Feinendegen LE
    Nucl Med Commun; 1989 May; 10(5):325-34. PubMed ID: 2787007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiopharmaceutical dosage of 99Tcm-HMPAO for cerebral blood flow SPET studies in children.
    Vestergren E; Jacobsson L; Bjure J; Sixt R; Mattsson S
    Nucl Med Commun; 1996 May; 17(5):423-9. PubMed ID: 8736520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
    Marshall DS; Newberry NR; Ryan PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO).
    Holmes RA; Chaplin SB; Royston KG; Hoffman TJ; Volkert WA; Nowotnik DP; Canning LR; Cumming SA; Harrison RC; Higley B
    Nucl Med Commun; 1985 Aug; 6(8):443-7. PubMed ID: 3877890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.